Innovative Aerosystems (ISSC) Q3 2026 Earnings Call Transcript

Innovative Aerosystems (ISSC) reported Q3 FY2026 results in an earnings call. The company said revenue rose about 11% to $20.7 million, with net income of $4.5 million ($0.25 diluted share). Gross margin rose to nearly 52% and adjusted EBITDA grew about 75%. It also discussed the Aiden Displays acquisition, an eVTOL OEM contract, and a Nasdaq ticker change to IA on Aug. 18.

Original reporting
Published Aug 14, 2026, 2:45 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 14, 2026, 2:51 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Innovative Aerosystems (ISSC) Q3 2026 Earnings Call Transcript — source image
Decision brief

The 30-second read

$ISSCBullishMed
01

Why it matters

Traders can focus on (1) the reported Q3 financial improvements, (2) the stated timing for engineering and production on the eVTOL program, (3) the acquisition’s strategic rationale, and (4) the Aug 18 Nasdaq ticker change plus small-cap index inclusion, which can create short-term trading and tracking effects.

02

Market read

The combination of Q3 margin expansion and multiple forward program milestones can shift expectations for defense and advanced air mobility avionics demand, while the Aug 18 ticker change and index inclusion can drive technical trading effects.

03

What to watch

The transcript mentions multiple program milestones (UMS2 production, L3 radio management unit, KC-767) but provides limited quantitative guidance for fiscal 26-27, making it harder to underwrite near-term revenue trajectory.

Relevance 7/10Novelty 6/10Timing: Aug 18 Nasdaq ticker change effective at US market open, plus Q3 earnings call details.

Background

Innovative Aerosystems (formerly ISSC) held a Q3 2026 earnings call, highlighting organic growth, margin expansion, an acquisition of Aiden Displays, and a new eVTOL OEM contract tied to its Liberty flight deck.

Company-level read

Ticker impact

$ISSCBullishMedium confidence
Context

Innovative Aerosystems reports Q3 results and progress on an acquisition and an OEM eVTOL contract, plus a planned Nasdaq ticker change.

Expected impact

Moderately positive bias, with potential volatility around the Aug 18 ticker change and any follow-on contract/production updates.

Evidence & confidence

The transcript discloses specific financial improvements (revenue, net income, gross margin, adjusted EBITDA) and concrete timing for engineering/production, which can re-rate expectations. However, it is an earnings call transcript rather than a fresh standalone filing, and the ticker-change mechanics may drive short-term technical effects more than fundamentals.

Market effects

Supports the defense and advanced air mobility avionics supply chain narrative via new OEM program development and display technology expansion.

Burdsboro, PA facility expansion and manufacturing transition could reinforce regional aerospace supplier employment and capex expectations.

Japanese eVTOL program development and 400+ order book references tie the story to cross-border advanced aviation demand.

Counterpoint

Large margin and EBITDA growth may be partly mix and timing-driven (e.g., prior-year F-16 pull-forward), so forward execution risk remains high for eVTOL production ramp.

Key entities

  • Innovative Aerosystems

    Reports Q3 2026 results, acquisition of Aiden Displays, and a new eVTOL OEM contract; announces Nasdaq ticker change to IA effective Aug 18.

  • Aiden Displays

    Rugged display technology developer acquired by Innovative Aerosystems, supporting 20+ military platforms and expanding into industrial applications.

  • L3

    Referenced for a radio management unit contract in final certification with production deliveries targeted for Q1 fiscal 27.

  • Boeing

    Referenced for KC-767 contract progressing per plan with production deliveries targeted for Q2 fiscal 27.

Related articles

$SBCHigh

Why SBC Medical Stock Skyrocketed on Friday

SBC Medical Group (NASDAQ:SBC) shares rose 37% after reporting Q3 revenue of $59M, up 35% YoY, and announcing an AI partnership with NeuroBrain Dynamics. The company added 36 clinics, increasing total locations to 293, and saw a 9% rise in patient visits. Operating income surged 66% to $26M, with a 45% operating margin.

$BTOMedAI 8/10

B2Gold Earnings Call Signals Lower Costs and Growth

B2Gold Corp. reported Q3 earnings with strong production, lower cost guidance, and positive free cash flow. The company produced 193,000 ounces of gold, reduced all-in sustaining cost guidance by over $100 per ounce, and generated $48 million in free cash flow. Revenue reached $836 million, supported by higher gold prices. The company also highlighted growth projects and shareholder returns.

$NMAXMed

Why Newsmax Stock Popped on Friday

Newsmax (NMAX) shares rose 31% after reporting Q3 revenue of $69M, up 52.5% YoY, and net income of $15.2M. The company cited strong audience engagement and growth in high-margin revenue streams. CEO Christopher Ruddy expects continued growth ahead of the presidential election.

$LUNRMed

What Is Driving Intuitive Machines Stock?

Intuitive Machines (LUNR) shares rose 7.0% on Nov 12, 2026, after reporting Q3 revenue of $269M, beating estimates. The company's loss of $0.10 per share met expectations, while gross margin improved to 26%. Free cash flow turned positive at $33M, a company record. Management raised full-year revenue guidance to $920M-$950M. The stock's performance contrasted with broader industry declines.

$RMIXMedAI 8/10

Suncrete (RMIX) Q3 2026 Earnings Call Transcript

Suncrete (RMIX) reported Q3 2026 revenue of $141M, up 45% QoQ and 163% YoY. Adjusted EBITDA rose 66% QoQ to $22.4M. The company lowered its full-year outlook due to residential construction weakness but remains confident in long-term demand. Acquisition integration is progressing, with North Texas showing margin improvement. Suncrete expects $200M-$250M revenue from 2026 acquisitions in 2027. The company has $206.5M in total liquidity.

$CLLSMed

Cellectis SA (CLLS) (Q3 2026) Earnings Call Highlights: Strategic Shift to Gene

Cellectis SA (CLLS) discussed its strategic shift to gene editing during its Q3 2026 earnings call. Management highlighted the selection of APOC3 over ANGPTL3 for triglyceride reduction, with plans to start Phase 1 dosing by end-2027. The company reported $149M in cash as of September 30, 2026, with a runway into H2 2028. Revenue decreased to $19.9M from $67.4M YoY, while R&D expenses increased to $108.8M from $69.1M, driven by the AstraZeneca collaboration.